Traders should monitor for potential downward pressure on the stock, especially given the broad-based nature of the selling among top executives. While the dollar amount is not massive relative to market cap, the coordination and participation of the entire C-suite raises concerns about internal sentiment ahead of upcoming catalysts or earnings.
Price Chart
Executive Summary
Multiple executives at MapLight Therapeutics, including CEO Christopher Kroeger and CFO Vishwas Setia, sold shares in a coordinated cluster over two days, totaling $572K in open-market sales. The transactions represent a modest but notable insider selling wave, with C-suite executives accounting for the majority of the volume.
Key Financial Metrics
Key Facts
- CEO Christopher Kroeger sold 11,612 shares for $312,909 across two days (April 15–16)
- CFO Vishwas Setia sold 2,835 shares for $76,181, including a small follow-on sale on April 16
- All 7 C-suite officers sold shares, totaling $477K in combined value over the 7-day window
- Director Robert Malenka sold $231K worth of stock, the second-largest transaction
- Total open-market selling by insiders in the last 7 days: $572K
- No insider purchases were reported during this period
Financial Impact
$572,000 in insider sales over 7 days, representing ~0.048% of $1.2B market cap
Risk Factors
- Perception of lack of confidence from executive leadership
- Potential for follow-on selling or negative news flow in the near term
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MPLT-1776456330358 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $8.17 (−2.13%) |
Oct 15, 2026 12d ago | 144 | $7.70 | awaiting T+20 | — | $8.17 (+6.10%) |
Oct 15, 2026 12d ago | 144 | $7.70 | awaiting T+20 | — | $8.17 (+6.10%) |
Oct 15, 2026 12d ago | 144 | $7.70 | awaiting T+20 | — | $8.17 (+6.10%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $8.17 (−24.07%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $8.17 (−25.05%) |
Aug 4, 2026 12w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $8.17 (−36.76%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $8.17 (−36.86%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $8.17 (+37.25%) |
Jul 28, 2026 13w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $8.17 (−45.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers